Literature DB >> 16685421

Human membrane protein Tim-3 facilitates hepatitis A virus entry into target cells.

Lili Sui1, Wenyuan Zhang, Yong Chen, Yuanyuan Zheng, Tao Wan, Weiping Zhang, Yadong Yang, Guojian Fang, Jiangsen Mao, Xuetao Cao.   

Abstract

In this study, a cellular surface membrane protein of immunoglobulin (Ig) superfamily (IgSF) was identified from a human dendritic cell (DC) cDNA library by large-scale random sequencing, which is identical to previously reported Tim-3 (T-cell Ig- and mucin-domain-containing molecule 3). Recent data have suggested the association of the 281-residue mouse Tim-3 molecule with Th1-related T cell responses and disease in mice. Human Tim-3 is a 301-residue type I membrane protein whose extracellular region contains a Cys-rich Ig-like domain and a mucin domain, the characteristics of Tim proteins. It shows significant homology to human hepatitis A virus (HAV) cellular receptor-1 (HuHAVcr-1)/Tim-1. Human Tim-3 mRNA was highly expressed in monocytes or monocyte-derived cells, and the expression level decreased when DC underwent maturation and activation. There is no previous report on the biological functions of human Tim-3, especially the involvement in virus infection. We demonstrated that HeLa cells, which are refractory to HAV infection, acquired a limited susceptibility to HAV infection after stably overexpressing human Tim-3 as confirmed by Western blot analysis using anti-Tim-3 antibody, but Tim-3-Fc fusion protein had no direct HAV-binding activity. The results indicated that human Tim-3 can promote HAV entry into target cells but itself may not function as a cellular receptor of HAV.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16685421

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  7 in total

1.  Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity.

Authors:  Lishomwa C Ndhlovu; Sandra Lopez-Vergès; Jason D Barbour; R Brad Jones; Aashish R Jha; Brian R Long; Eric C Schoeffler; Tsuyoshi Fujita; Douglas F Nixon; Lewis L Lanier
Journal:  Blood       Date:  2012-03-01       Impact factor: 22.113

Review 2.  TIM polymorphisms--genetics and function.

Authors:  J Lee; B Phong; A M Egloff; L P Kane
Journal:  Genes Immun       Date:  2011-11-03       Impact factor: 2.676

3.  Phosphatidylserine vesicles enable efficient en bloc transmission of enteroviruses.

Authors:  Ying-Han Chen; WenLi Du; Marne C Hagemeijer; Peter M Takvorian; Cyrilla Pau; Ann Cali; Christine A Brantner; Erin S Stempinski; Patricia S Connelly; Hsin-Chieh Ma; Ping Jiang; Eckard Wimmer; Grégoire Altan-Bonnet; Nihal Altan-Bonnet
Journal:  Cell       Date:  2015-02-12       Impact factor: 41.582

Review 4.  Inhibitor-Based Therapeutics for Treatment of Viral Hepatitis.

Authors:  Debajit Dey; Manidipa Banerjee
Journal:  J Clin Transl Hepatol       Date:  2016-09-25

Review 5.  Induction and Suppression of Innate Antiviral Responses by Hepatitis A Virus.

Authors:  Xin Cao; Yu-Jia Xue; Jiang-Long Du; Qiang Xu; Xue-Cai Yang; Yan Zeng; Bo-Bo Wang; Hai-Zhen Wang; Jing Liu; Kui-Zheng Cai; Zhong-Ren Ma
Journal:  Front Microbiol       Date:  2018-08-17       Impact factor: 5.640

Review 6.  Translational Implication of Galectin-9 in the Pathogenesis and Treatment of Viral Infection.

Authors:  Jenn-Haung Lai; Shue-Fen Luo; Mei-Yi Wang; Ling-Jun Ho
Journal:  Int J Mol Sci       Date:  2017-10-08       Impact factor: 5.923

Review 7.  Molecular biology and inhibitors of hepatitis A virus.

Authors:  Yannick Debing; Johan Neyts; Hendrik Jan Thibaut
Journal:  Med Res Rev       Date:  2013-05-30       Impact factor: 12.944

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.